Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

526 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer.
Patil V, Noronha V, Joshi A, Chougule A, Kannan S, Bhattacharjee A, Goud S, More S, Chandrasekharan A, Menon N, Srinivas S, Vallathol DH, Dsouza H, Majumdar S, Das S, Zawar A, Khaddar S, Kumar A, Singh G, Kumar KAP, Ravind R, Trivedi V, Behel V, Mahajan A, Janu A, Purandare N, Prabhash K. Patil V, et al. Among authors: menon n. EClinicalMedicine. 2019 Apr 9;9:19-25. doi: 10.1016/j.eclinm.2019.03.011. eCollection 2019 Mar. EClinicalMedicine. 2019. PMID: 31143878 Free PMC article.
Aprepitant for Cough Suppression in Advanced Lung Cancer: A Randomized Trial.
Noronha V, Bhattacharjee A, Patil VM, Joshi A, Menon N, Shah S, Kannan S, Mukadam SA, Maske K, Ishi S, Prabhash K. Noronha V, et al. Among authors: menon n. Chest. 2020 Jun;157(6):1647-1655. doi: 10.1016/j.chest.2019.11.048. Epub 2020 Jan 18. Chest. 2020. PMID: 31958446 Clinical Trial.
Reverse swing-M, phase 1 study of repurposing mebendazole in recurrent high-grade glioma.
Patil VM, Bhelekar A, Menon N, Bhattacharjee A, Simha V, Abhinav R, Abhyankar A, Sridhar E, Mahajan A, Puranik AD, Purandare N, Janu A, Ahuja A, Krishnatry R, Gupta T, Jalali R. Patil VM, et al. Among authors: menon n. Cancer Med. 2020 Jul;9(13):4676-4685. doi: 10.1002/cam4.3094. Epub 2020 May 13. Cancer Med. 2020. PMID: 32400117 Free PMC article. Clinical Trial.
Safety and efficacy of bevacizumab biosimilar in recurrent/ progressive glioblastoma.
Kumar G, DSouza H, Menon N, Srinivas S, Vallathol DH, Boppana M, Rajpurohit A, Mahajan A, Janu A, Chatterjee A, Krishnatry R, Gupta T, Jalali R, Patil VM. Kumar G, et al. Among authors: menon n. Ecancermedicalscience. 2021 Jan 13;15:1166. doi: 10.3332/ecancer.2021.1166. eCollection 2021. Ecancermedicalscience. 2021. PMID: 33680080 Free PMC article.
Intensity-modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single institute.
Laskar SG, Pai P, Sinha S, Budrukkar A, Nair D, Swain M, Mummudi N, Gupta T, Murthy V, Agarwal JP, Tiwari N, Thiagrajan S, Chaukar D, Chaturvedi P, Pantvaidya G, Deshmukh A, Nair S, Prabhash K, Joshi A, Noronha V, Patil V, Menon N, Patil A, Bal M, Mittal N, Rane S. Laskar SG, et al. Among authors: menon n. Head Neck. 2021 Jul;43(7):2045-2057. doi: 10.1002/hed.26669. Epub 2021 Mar 9. Head Neck. 2021. PMID: 33687114
Post-cricoid and Upper Oesophagus Cancers Treated with Organ Preservation Using Intensity-modulated Image-guided Radiotherapy: a Phase II Prospective Study of Outcomes, Toxicity and Quality of Life.
Laskar SG, Sinha S, Singh M, Mummudi N, Mittal R, Gavarraju A, Budrukkar A, Swain M, Agarwal JP, Gupta T, Murthy V, Mokal S, Patil V, Noronha V, Joshi A, Menon N, Prabhash K. Laskar SG, et al. Among authors: menon n. Clin Oncol (R Coll Radiol). 2022 Apr;34(4):220-229. doi: 10.1016/j.clon.2021.11.012. Epub 2021 Dec 3. Clin Oncol (R Coll Radiol). 2022. PMID: 34872822 Clinical Trial.
Definitive and adjuvant radiation therapy for external auditory canal and temporal bone squamous cell carcinomas: Long term outcomes.
Laskar SG, Sinha S, Pai P, Nair D, Budrukkar A, Swain M, Kumar A, Moiyadi A, Shetty P, Ray V, Johnny C, Murthy V, Gupta T, Menon N, Patil V, Noronha V, Joshi A, Prabhash K, Agarwal JP. Laskar SG, et al. Among authors: menon n. Radiother Oncol. 2022 May;170:151-158. doi: 10.1016/j.radonc.2022.02.021. Epub 2022 Feb 24. Radiother Oncol. 2022. PMID: 35219800
Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trial.
Noronha V, Patil VM, Menon NS, Joshi A, Goud S, More S, Kannan S, Pawar A, Nakti D, Yadav A, Shah S, Mahajan A, Janu A, Kumar R, Tibdewal A, Mummudi N, Agarwal JP, Banavali SD, Prabhash K. Noronha V, et al. Among authors: menon ns. Esophagus. 2022 Oct;19(4):670-682. doi: 10.1007/s10388-022-00923-8. Epub 2022 May 26. Esophagus. 2022. PMID: 35614161 Clinical Trial.
Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial.
Patil VM, Menon N, Chatterjee A, Tonse R, Choudhari A, Mahajan A, Puranik AD, Epari S, Jadhav M, Pathak S, Peelay Z, Walavalkar R, Muthuluri HK, Ravi Krishna M, Chandrasekharan A, Pande N, Gupta T, Banavali S, Jalali R. Patil VM, et al. Among authors: menon n. EClinicalMedicine. 2022 May 27;49:101449. doi: 10.1016/j.eclinm.2022.101449. eCollection 2022 Jul. EClinicalMedicine. 2022. PMID: 35747192 Free PMC article.
526 results